Status:

UNKNOWN

Impact of Body Composition on Bisoprolol and Ramipril Pharmacokinetics in Patients With Chronic Heart Failure

Lead Sponsor:

The University Clinic of Pulmonary and Allergic Diseases Golnik

Conditions:

Chronic Heart Failure

Cachexia

Eligibility:

All Genders

18+ years

Brief Summary

The purpose of this study is to determine if cachexia and changes in body composition influence pharmacokinetics of bisoprolol and ramipril and the accuracy of equations for renal function estimation.

Detailed Description

Patients with chronic heart failure on treatment with bisoprolol and/or ramipril will be included. Study will consist of two study visits: baseline visit (V1) and visit which will be performed at leas...

Eligibility Criteria

Inclusion

  • Diagnosis of chronic heart failure of New York Heart Association Functional Classification (NYHA) class II and III
  • On treatment with bisoprolol for at least 3 days and/or ramipril for at least 4 days before V1
  • Able and willing to provide freely given written informed consent

Exclusion

  • Chronic renal disease with estimated glomerular filtration rate calculated by Modification of Diet in Renal Disease (MDRD) equation \< 40 mL/(min x 1,73 m2) at V1 or V2
  • Liver disease or increased serum liver enzymes (bilirubin \> 1.5 x normal, gamma-glutamyl transpeptidase (GGT) \> 2.5 x normal, aspartate transaminase (AST) \> 2.5 x normal, alanine transaminase (ALT) \> 2.5 x normal) at V1 or V2
  • Absence of bisoprolol or ramipril steady state concentrations at V1 or V2 or withdrawal of bisoprolol and/or ramipril in-between both visits
  • Acute decompensation of heart failure in less than 4 weeks before V1 or V2
  • Addition, withdrawal or change in dose of drugs that importantly influence bisoprolol or ramipril pharmacokinetics in-between V1 and V2
  • Unable to understand and comply with protocol or to give informed consent

Key Trial Info

Start Date :

October 1 2011

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

August 1 2013

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT01829880

Start Date

October 1 2011

End Date

August 1 2013

Last Update

April 11 2013

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University Clinic of Respiratory and Allergic Diseases Golnik

Golnik, Slovenia, 4204